Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BGF Retail | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩2.03T | 11.6x | -2 | ₩117,300 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.1% Upside | Upgrade to Pro+ | |
E-Mart | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩1.92T | -4.3x | 0.02 | ₩71,500 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gs Retail | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩1.35T | -16.3x | 0.06 | ₩16,210 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11% Upside | Upgrade to Pro+ | |
Hyundai Green Food | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩528.88B | 6.9x | 0.33 | ₩16,100 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.1% Downside | Upgrade to Pro+ | |
SPC Samlip | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩435.25B | 10x | -0.21 | ₩53,700 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CJ Freshway | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩350.81B | 13.9x | ₩29,550 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.3% Upside | Upgrade to Pro+ | ||
Curexo | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩338.17B | -13.8x | ₩8,230 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kyochon | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩242.33B | 19.5x | 0.28 | ₩4,850 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinsegae Food | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩158.76B | 7.3x | 0.12 | ₩41,000 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22% Upside | Upgrade to Pro+ | |
Seouleaguer | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩84.66B | -258.4x | 0.25 | ₩978 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boratr | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩61.5B | 9.6x | -0.28 | ₩9,390 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nara Cellar | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩34.69B | -7.6x | 0.24 | ₩2,790 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KBio Company | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩31.76B | -2.7x | ₩275 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CuroHoldings | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩17.2B | -0.7x | 0.02 | ₩742 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |